Qatar Petroleum, Sasol Chevron sign MOU for GTL base oil project
- Publisher
- Elsevier Science
- Year
- 2005
- Weight
- 38 KB
- Volume
- 2005
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
✦ Synopsis
VioQuest Pharmaceuticals expands commercial catalyst portfolio
VioQuest Pharmaceuticals Inc is pleased to announce that subsidiary Chiral Quest has introduced its proprietary chiral catalyst DuanPhos for commercial-scale shipping on a kilogram scale. VioQuest, in addition to acquiring innovative oncologic, metabolic, and anti-inflammatory therapeutic compounds for unmet medical needs, offers a growing family of latest generation technology in the manufacture of optically pure therapeutics for the pharmaceutical industry. VioQuest Pharmaceuticals Inc is a drug development company focused on acquiring and bringing to market therapies for oncology, metabolic, and inflammatory diseases and disorders that are current unmet medical needs.